James G. Baxter
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Antibiotics Pharmacokinetics and Efficacy
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
Papers in
-
- Pharmacogenetics and Drug Metabolism 6
- Antibiotics Pharmacokinetics and Efficacy 2
-
- Enzyme Catalysis and Immobilization 1
- Cancer therapeutics and mechanisms 1
- Co-authors
- David J. Rance (2 shared papers)B. Michael Silber (2 shared papers)Fiona Macintyre (2 shared papers)Philip Wastall (2 shared papers)Theodore E. Liston (2 shared papers)R. Scott Obach (1 shared paper)B. Jones (1 shared paper)Barry Jones (1 shared paper)
- Journals
- Annals of Surgery (1 paper)Clinical Pharmacokinetics (1 paper)Journal of the American Chemical Society (1 paper)Journal of Pharmaceutical Sciences (1 paper)Drug Metabolism and Disposition (1 paper)
- Partner nations
- United StatesSwitzerlandCanada
In The Last Decade
James G. Baxter
9 papers receiving 1.2k citations
James G. Baxter's Hit Papers
Peers
Comparison fields: 5 of 99
- Pharmacology 506
- Oncology 353
- Computational Theory and Mathematics 181
- Pharmacology 145
- Spectroscopy 154
Countries citing papers authored by James G. Baxter
This map shows the geographic impact of James G. Baxter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James G. Baxter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James G. Baxter more than expected).
Fields of papers citing papers by James G. Baxter
This network shows the impact of papers produced by James G. Baxter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James G. Baxter. The network helps show where James G. Baxter may publish in the future.
Co-authors
The 25 scholars most cited alongside James G. Baxter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data. Hit paper breakdown → | 1997 | 506 |
| 2 | 1997 | 471 | |
| 3 | 1986 | 152 | |
| 4 | 1955 | 59 | |
| 5 | 1986 | 47 | |
| 6 | 2003 | 26 | |
| 7 | 1985 | 24 | |
| 8 | Metabolism and excretion of a new anxiolytic drug candidate, CP-93, 393, in healthy male volunteers. | 1998 | 8 |
| 9 | 1992 | 3 |
About James G. Baxter
James G. Baxter is a scholar working on Pharmacology, Molecular Biology, Oncology, Pharmacology and Anesthesiology and Pain Medicine, having authored 9 papers that have together received 1.3k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (6 papers), Drug Transport and Resistance Mechanisms (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Vitamin K Research Studies (1 paper), Enzyme Catalysis and Immobilization (1 paper), Cancer therapeutics and mechanisms (1 paper), Analytical Methods in Pharmaceuticals (1 paper) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Pharmacology (506 citations), Oncology (353 citations), Computational Theory and Mathematics (181 citations), Pharmacology (145 citations) and Spectroscopy (154 citations). James G. Baxter has collaborated with scholars based in United States, Switzerland and Canada. Frequent co-authors include David J. Rance, B. Michael Silber, Fiona Macintyre, Philip Wastall, Theodore E. Liston, R. Scott Obach, B. Jones, Barry Jones, David Lalka and Craig K. Svensson. Their work appears in journals such as Annals of Surgery, Clinical Pharmacokinetics, Journal of the American Chemical Society, Journal of Pharmaceutical Sciences and Drug Metabolism and Disposition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.